Posted innews
FDA Issues Urgent Alert: Antidepressants Containing Possible Carcinogen Reach Second-Highest Risk Level in Duloxetine Recall
The Food and Drug Administration (FDA) has announced a recall of another commonly prescribed antidepressant due to potential cancer-causing chemicals. On November 19, Rising Pharma, Inc., recalled several doses of…
